US 12359178
Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfatase
granted A61KA61K38/465A61P
Quick answer
US patent 12359178 (Methods and compositions for treatment of hunter syndrome comprising iduronate-2-sulfatase) held by Takeda Pharmaceutical Company Limited expires Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Jul 15 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 10 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K38/465, A61P, A61P25/00, A61P3/00